Richard Lowenthal

Richard E.
Lowenthal is the founder of ARS Pharmaceuticals Operations, Inc., founded in 2015, serving as President, Chief Executive Officer & Director since 2018.
Mr. Lowenthal was the founder of Pacific-Link Regulatory Consulting, founded in 2007, serving as President.
Mr. Lowenthal was the founder of ARS Pharmaceuticals, Inc., founded in 2015, serving as Chief Executive Officer & Director in 2026.
Former jobs include President & Chief Executive Officer at MTG Biotherapeutics, Inc. from 2014 to 2017; Chairman at American Association of Pharmaceutical Scientists; Director-Regulatory Affairs & Quality Assurance at Somerset Pharmaceuticals, Inc. in 1996; Director at Momotaro-Gene, Inc. from 2014 to 2017; Global Director-Regulatory Affairs at The Janssen Research Foundation from 1995 to 2001; President-Pacific Link Regulatory Consulting at Research, Inc. from 2007 to 2015; Head-Worldwide Regulatory Affairs & Drug Safety at Maxim Pharmaceuticals, Inc. in 2004; VP-Regulatory Affairs & Quality Assurance at AnGes, Inc. in 2002; VP-Regulatory Affairs & Quality Assurance at Mallinckrodt Hospital Products, Inc. from 2004 to 2007; Regulatory Affairs Officer at Vecta Ltd.; and Member-Corporate Council at The National Organization for Rare Disorders, Inc. Education includes graduate degrees from Florida State University and the University of San Diego.